97-13281. Issuer Delisting; Notice of Application to Withdraw From Listing and Registration; (Sparta Surgical Corporation, $4.00 Par Value Redeemable Preferred Stock; $4.00 Par Value Series A Convertible Redeemable Preferred Stock; Series A Common ...

[Federal Register Volume 62, Number 98 (Wednesday, May 21, 1997)]
[Notices]
[Pages 27813-27814]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13281]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application to Withdraw From Listing 
and Registration; (Sparta Surgical Corporation, $4.00 Par Value 
Redeemable Preferred Stock; $4.00 Par Value Series A Convertible 
Redeemable Preferred Stock; Series A Common Stock Purchase Warrants) 
File No. 1-11047

May 15, 1997.
    Sparta Surgical Corporation (``Company'') has filed an application 
with the Securities and Exchange Commission (``Commission''), pursuant 
to Section 12(d) of the Securities Exchange Act of 1934 (``Act'') and 
Rule 12d2-2(d) promulgated thereunder, to withdraw the above specified 
securities (``Securities'') from listing and registration on the Boston 
Stock Exchange, Inc. (``BSE'' or ``Exchange'').
    The reasons cited in the application for withdrawing the Securities 
from listing and registration include the following:
    According to the Company, it has complied with rules of the BSE by 
filing with such Exchange a copy of resolution adopted by the Company's 
Board of Directors authorizing the withdrawal of its securities from 
listing on the BSE and by setting forth in detail to such Exchange the 
reasons for such proposed withdrawal, and the facts in support thereof. 
The Securities of the Company have been listed on the Nasdaq Stock 
Market since March 12, 1992 and July 12, 1994. In making the decision 
to withdraw the Securities from listing on the BSE, the Company 
considered the direct and indirect costs and expenses attendant on 
maintaining the dual listing of its securities on the Nasdaq Stock 
Market and the BSE.
    Any interested person may, on or before June 5, 1997, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, N.W., Washington, D.C. 20549, facts bearing upon whether 
the application has been made in accordance with the rules of the 
exchange and what terms, if any, should be imposed by Commission for 
the protection of investors. The Commission, based on the information 
submitted to it, will issue an order granting the application

[[Page 27814]]

after the date mentioned above, unless the Commission determines to 
order a hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.
Jonathan G. Katz,
Secretary.
[FR Doc. 97-13281 Filed 5-20-97; 8:45 am]
BILLING CODE 8010-01-M